weight loss/inflammation

BACKGROUND OF THE INVENTION The present invention relates to a therapeutic method for treating weight loss linked to inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerative colitis. Inflammatory bowel diseases are chronic relapsing conditions of the intestinal tract for which

TECHNICAL FIELD The present invention relates to a composition for treating inflammatory brain diseases, comprising stem cells as an active ingredient. BACKGROUND ART Stem cells refer to cells having the ability to self-replicate and the ability to differentiate into at least two cells and can be

FEDERALLY SPONSORED RESEARCH Not Applicable SEQUENCE LISTING OR PROGRAM Not Applicable BACKGROUND OF THE INVENTION 1. Field of Invention The present application generally relates to nutrition, in particular an ultra-high fiber supplement, the making of the supplement, and its use in weight loss,

FEDERALLY SPONSORED RESEARCH Not Applicable SEQUENCE LISTING OR PROGRAM Not Applicable BACKGROUND OF THE INVENTION 1. Field of Invention The present application generally relates to nutrition, in particular an ultra-high fiber supplement, the making of the supplement, and its use in weight loss,

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a composition, and more particularly to the composition for reducing localized fat or promoting weight loss. The present invention also relates to a method of said composition, and more particularly to the method

INCORPORATION BY REFERENCE OF MATERIAL IN ASCII TEXT FILE This application incorporates by reference the Sequence Listing contained in the following ASCII text file being submitted concurrently herewith: a) File name: 32681000038SEQ.txt; created 2-22-12, 1.36 KB in size. TECHNICAL FIELD OF THE

TECHNICAL FIELD OF THE INVENTION The present invention provides a pharmaceutical composition and method for treating diseases characterized by activation of an inflammatory cytokine cascade, particularly sepsis, including septic shock and ARDS (acute respiratory distress syndrome), comprising

TECHNICAL FIELD OF THE INVENTION The present invention provides a pharmaceutical composition and method for treating diseases characterized by activation of an inflammatory cytokine cascade, particularly sepsis, including septic shock and ARDS (acute respiratory distress syndrome), comprising

TECHNICAL FIELD OF THE INVENTION The present invention provides a pharmaceutical composition and method for treating diseases characterized by activation of an inflammatory cytokine cascade, particularly sepsis, including septic shock and ARDS (acute respiratory distress syndrome), comprising

TECHNICAL FIELD OF THE INVENTION The present invention provides a pharmaceutical composition and method for treating diseases characterized by activation of an inflammatory cytokine cascade, particularly sepsis, including septic shock and ARDS (acute respiratory distress syndrome), comprising

TECHNICAL FIELD OF THE INVENTION The present invention provides a pharmaceutical composition and method for treating diseases characterized by activation of an inflammatory cytokine cascade, particularly sepsis, including septic shock and ARDS (acute respiratory distress syndrome), comprising

TECHNICAL FIELD OF THE INVENTION The present invention provides a pharmaceutical composition and method for treating diseases characterized by activation of an inflammatory cytokine cascade, particularly sepsis, including septic shock and ARDS (acute respiratory distress syndrome), comprising

FIELD OF THE INVENTION The present invention relates to a composition, and more particularly to a composition used for reducing localized fat and reducing weight. The present invention relates to an application of the composition, and more particularly to the application used for reducing localized

CROSS REFERENCE TO RELATED APPLICATION This application claims priority under 35 U.S.C. .sctn.119(e) to U.S. Provisional Application No. 61/211,527, filed Mar. 31, 2009, which application is incorporated by reference herein in its entirety. FIELD OF INVENTION The invention relates to leptin

The present invention relates to a new class of 2-bromo-6-fluoro pregnanes. More particularly, the present invention relates to 2-bromo-6.beta.-fluoro-3-keto-.DELTA..sup.1,4 -steroids of the pregnane series which possess valuable pharmacological properties, particularly anti-inflammatory and